| Literature DB >> 26232369 |
Stephen Y Lai1, C David Fuller2, Pratip K Bhattacharya3, Steven J Frank4.
Abstract
(13)C-pyruvate hyperpolarized magnetic resonance imaging (HP-MRI) is emerging as a viable quantitative biomarker for solid tumor response and normal tissue toxicity after radiotherapy. This technology effectively predicts response related to metabolic agents or alterations in the tumor microenvironment, but challenges remain to be addressed to ensure successful translational implementation. See related article by Saito et al., p. 5073. ©2015 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26232369 PMCID: PMC4644683 DOI: 10.1158/1078-0432.CCR-15-1214
Source DB: PubMed Journal: Clin Cancer Res ISSN: 1078-0432 Impact factor: 12.531